THERESA REGIS: Open Payments
NPI 1609843358 · VERO BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$873 in 30 payments from 17 companies in 2025. Trend: 2023 $701 · 2024 $459 · 2025 $873
Food & beverage: $873
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $137 |
| Novo Nordisk Inc | 2 | $116 |
| EMD Serono, Inc. | 4 | $98 |
| ABBVIE INC. | 4 | $97 |
| Lundbeck LLC | 2 | $57 |
| Lilly USA, LLC | 3 | $57 |
| Corcept Therapeutics | 2 | $43 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| Genentech USA, Inc. | 1 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
Products named: AIRSUPRA, Ozempic, QULIPTA, Korlym, AMYVID, TRELEGY ELLIPTA, VYEPTI, Ocrevus Zunovo.
Industry payments across FL — which companies pay providers there.
